Publications – Seda https://www.sedapds.com Wed, 05 Nov 2025 20:35:39 +0000 en-GB hourly 1 Advances in Nasal Biopharmaceutics to Support Product Development and Therapeutic Needs https://www.sedapds.com/publication/open-accessreview-advances-in-nasal-biopharmaceutics-to-support-product-development-and-therapeutic-needs/?utm_source=rss&utm_medium=rss&utm_campaign=open-accessreview-advances-in-nasal-biopharmaceutics-to-support-product-development-and-therapeutic-needs Wed, 05 Nov 2025 20:35:04 +0000 https://www.sedapds.com/?post_type=publication&p=2477 The post Advances in Nasal Biopharmaceutics to Support Product Development and Therapeutic Needs appeared first on Seda.

]]> The post Advances in Nasal Biopharmaceutics to Support Product Development and Therapeutic Needs appeared first on Seda.

]]> Long-Acting Injectable Dose Prediction: Where Are We Really? https://www.sedapds.com/publication/long-acting-injectable-dose-prediction-where-are-we-really/?utm_source=rss&utm_medium=rss&utm_campaign=long-acting-injectable-dose-prediction-where-are-we-really Thu, 17 Jul 2025 13:08:12 +0000 https://www.sedapds.com/?post_type=publication&p=2453 The post Long-Acting Injectable Dose Prediction: Where Are We Really? appeared first on Seda.

]]> The post Long-Acting Injectable Dose Prediction: Where Are We Really? appeared first on Seda.

]]> Surge Dose® Formulations of NSAIDs Provide for Ultra-Rapid and Consistent Drug Absorption in Both the Fasted and Fed State as Predicted by Physiologically Based Biopharmaceutics Modelling https://www.sedapds.com/publication/surge-dose-formulations-of-nsaids-provide-for-ultra-rapid-and-consistent-drug-absorption-in-both-the-fasted-and-fed-state-as-predicted-by-physiologically-based-biopharmaceutics-modelling/?utm_source=rss&utm_medium=rss&utm_campaign=surge-dose-formulations-of-nsaids-provide-for-ultra-rapid-and-consistent-drug-absorption-in-both-the-fasted-and-fed-state-as-predicted-by-physiologically-based-biopharmaceutics-modelling Thu, 12 Jun 2025 13:17:40 +0000 https://www.sedapds.com/?post_type=publication&p=2416 The post Surge Dose® Formulations of NSAIDs Provide for Ultra-Rapid and Consistent Drug Absorption in Both the Fasted and Fed State as Predicted by Physiologically Based Biopharmaceutics Modelling appeared first on Seda.

]]> The post Surge Dose® Formulations of NSAIDs Provide for Ultra-Rapid and Consistent Drug Absorption in Both the Fasted and Fed State as Predicted by Physiologically Based Biopharmaceutics Modelling appeared first on Seda.

]]> Translational PK/PD Modelling of MEK inhibitors: Trametinib, Cobimetinib and Binimetinib https://www.sedapds.com/publication/translational-pk-pd-modelling-of-mek-inhibitors-trametinib-cobimetinib-and-binimetinib/?utm_source=rss&utm_medium=rss&utm_campaign=translational-pk-pd-modelling-of-mek-inhibitors-trametinib-cobimetinib-and-binimetinib Thu, 08 May 2025 10:27:34 +0000 https://www.sedapds.com/?post_type=publication&p=2414 The post Translational PK/PD Modelling of MEK inhibitors: Trametinib, Cobimetinib and Binimetinib appeared first on Seda.

]]> The post Translational PK/PD Modelling of MEK inhibitors: Trametinib, Cobimetinib and Binimetinib appeared first on Seda.

]]> Harnessing GitLab, R and LaTeX to perform bespoke and robust non-compartmental analysis for patient SAD and MAD studies https://www.sedapds.com/publication/harnessing-gitlab-r-and-latex-to-perform-bespoke-and-robust-non-compartmental-analysis-for-patient-sad-and-mad-studies/?utm_source=rss&utm_medium=rss&utm_campaign=harnessing-gitlab-r-and-latex-to-perform-bespoke-and-robust-non-compartmental-analysis-for-patient-sad-and-mad-studies Wed, 27 Nov 2024 18:04:23 +0000 https://www.sedapds.com/?post_type=publication&p=2310 The post Harnessing GitLab, R and LaTeX to perform bespoke and robust non-compartmental analysis for patient SAD and MAD studies appeared first on Seda.

]]> The post Harnessing GitLab, R and LaTeX to perform bespoke and robust non-compartmental analysis for patient SAD and MAD studies appeared first on Seda.

]]> NCA Example Report https://www.sedapds.com/publication/nca-example-report/?utm_source=rss&utm_medium=rss&utm_campaign=nca-example-report Thu, 14 Nov 2024 13:49:59 +0000 https://www.sedapds.com/?post_type=publication&p=2282 The post NCA Example Report appeared first on Seda.

]]> The post NCA Example Report appeared first on Seda.

]]> Investigating the influence of manufacturing process of lipid-based formulations on intracellular delivery of siRNA https://www.sedapds.com/publication/investigating-the-influence-of-manufacturing-process-of-lipid-based-formulations-on-intracellular-delivery-of-sirna/?utm_source=rss&utm_medium=rss&utm_campaign=investigating-the-influence-of-manufacturing-process-of-lipid-based-formulations-on-intracellular-delivery-of-sirna Thu, 20 Jun 2024 15:10:23 +0000 https://www.sedapds.com/?post_type=publication&p=2223 The post Investigating the influence of manufacturing process of lipid-based formulations on intracellular delivery of siRNA appeared first on Seda.

]]> The post Investigating the influence of manufacturing process of lipid-based formulations on intracellular delivery of siRNA appeared first on Seda.

]]> Model Informed-Development of Amorphous Systems (MI-DAS) – an in-silico polymer selection tool for ASD development https://www.sedapds.com/publication/model-informed-development-of-amorphous-systems-mi-das-an-in-silico-polymer-selection-tool-for-asd-development/?utm_source=rss&utm_medium=rss&utm_campaign=model-informed-development-of-amorphous-systems-mi-das-an-in-silico-polymer-selection-tool-for-asd-development Fri, 05 Jan 2024 11:19:47 +0000 https://www.sedapds.com/?post_type=publication&p=1989 The post Model Informed-Development of Amorphous Systems (MI-DAS) – an in-silico polymer selection tool for ASD development appeared first on Seda.

]]> The post Model Informed-Development of Amorphous Systems (MI-DAS) – an in-silico polymer selection tool for ASD development appeared first on Seda.

]]> Explaining in-vitro to in-vivo efficacy correlations in oncology pre-clinical development via a semi-mechanistic mathematical model. https://www.sedapds.com/publication/explaining-in-vitro-to-in-vivo-efficacy-correlations-in-oncology-pre-clinical-development-via-a-semi-mechanistic-mathematical-model/?utm_source=rss&utm_medium=rss&utm_campaign=explaining-in-vitro-to-in-vivo-efficacy-correlations-in-oncology-pre-clinical-development-via-a-semi-mechanistic-mathematical-model Thu, 16 Nov 2023 14:19:54 +0000 https://www.sedapds.com/?post_type=publication&p=1959 The post Explaining in-vitro to in-vivo efficacy correlations in oncology pre-clinical development via a semi-mechanistic mathematical model. appeared first on Seda.

]]> The post Explaining in-vitro to in-vivo efficacy correlations in oncology pre-clinical development via a semi-mechanistic mathematical model. appeared first on Seda.

]]> Radius additivity score: a novel combination index for tumour growth inhibition in fixed-dose xenograft studies https://www.sedapds.com/publication/radius-additivity-score-a-novel-combination-index-for-tumour-growth-inhibition-in-fixed-dose-xenograft-studies/?utm_source=rss&utm_medium=rss&utm_campaign=radius-additivity-score-a-novel-combination-index-for-tumour-growth-inhibition-in-fixed-dose-xenograft-studies Wed, 15 Nov 2023 14:02:49 +0000 https://www.sedapds.com/?post_type=publication&p=1957 The post Radius additivity score: a novel combination index for tumour growth inhibition in fixed-dose xenograft studies appeared first on Seda.

]]> The post Radius additivity score: a novel combination index for tumour growth inhibition in fixed-dose xenograft studies appeared first on Seda.

]]>